Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells

mBio

Volumn 3, Issue 2, 2012, Pages

  Alemayehu, Debebe ^a,b   Casey, Pat G ^b   Mcauliffe, Olivia ^a   Guinane, Caitriona M ^a,b   Martin, James G ^c   Shanahan, Fergus ^b,d   Coffey, Aidan ^e   Ross, R Paul ^a,b   Hill, Colin ^b,d  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e Munster Technological University   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA BASE COMPOSITION; GENOME SIZE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MULTIDRUG RESISTANCE; MYOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOVIRUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEWAGE TREATMENT PLANT; VIRUS GENOME; VIRUS ISOLATION; VIRUS STRAIN; ANIMAL; BACTERIAL LOAD; BAGG ALBINO MOUSE; BIOLOGICAL THERAPY; BRONCHOPNEUMONIA; CELL LINE; CHEMISTRY; DISEASE MODEL; DNA SEQUENCE; EPITHELIUM CELL; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LUNG; METHODOLOGY; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; PSEUDOMONAS INFECTION; PSEUDOMONAS PHAGE; VIROLOGY;

MURINAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; T7-LIKE VIRUSES;

VIRUS DNA;

ANIMALS; BACTERIAL LOAD; BIOLOGICAL THERAPY; BRONCHOPNEUMONIA; CELL LINE; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; DNA, VIRAL; EPITHELIAL CELLS; FEMALE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MYOVIRIDAE; PODOVIRIDAE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES; SEQUENCE ANALYSIS, DNA; WATER MICROBIOLOGY;

EID: 84860511608     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00029-12     Document Type: Article

References (62)

1. Kerem B, et al. 1998. Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080.
2. Riordan JR, et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073.
3. Rommens JM, et al. 1998. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065.
4. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951.
5. Saiman L, Siegel J. 2004. Infection control in cystic fibrosis. Clin. Microbiol. Rev. 17:57-71.
6. Burns JL, et al. 2001. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183:444-452.
7. Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
8. Govan JR, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
9. Høiby N, Frederiksen B, Pressler T. 2005. Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibros. 4(Suppl. 2):49-54.
10. Lam J, Chan R, Lam K, Costerton JW. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28:546-556.
11. Pedersen SS. 1992. Lung infection with alginate-producing, mucoid P. aeruginosa in cystic fibrosis. APMIS 28(Suppl.):1-79.
12. Anderson GG, Moreau-Marquis S, Stanton BA, O'Toole GA. 2008. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect. Immun. 76: 1423-1433.
13. Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. 2005. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil. J. Antimicrob. Chemother. 56:1148-1151.
14. Pasca MR, et al. 2012. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. Microb. Drug Resist. 18:23-32.
15. Lyczak JB, Cannon CL, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2(9):1051-1060.
16. Azeredo A, Southerland WI. 2008. The use of phages for the removal of infectious biofilms. Curr. Pharm. Biotechnol. 9:261-266.
17. Cerca N, et al. 2005. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J. Antimicrob. Chemother. 56(2):331-336.
18. Monzón M, Oteiza C, Leiva J, Lamata M, Amorena B. 2002. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn. Microbiol. Infect. Dis. 44(4):319-324.
19. Travis J. 2000. Viruses that slay bacteria drew new interest. Science News 157:356-360.
20. Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ. 2008. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol. 104(1):1-13.
21. Fu W, et al. 2010. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54:397-404.
22. Knezevic P, Petrovic O. 2008. A colorimetric microtiter plate method for assessment of phage effect on Pseudomonas aeruginosa biofilm. J. Microbiol. Methods 74(2-3):114-118.
23. Glonti T, Chanishvili N, Taylor PW. 2010. Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J. Appl. Microbiol. 108(2): 695-702.
24. Morello E, et al. 2011. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 6(2):e16963.
25. Debarbieux L, et al. 2010. Bacteriophages can treat and prevent P. aeruginosa lung infections. Infect. Dis. 201(7):1096-1104.
26. Carmody LA, et al. 2010. Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. J. Infect. Dis. 201(2): 264-271.
27. Seed KD, Dennis JJ. 2009. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex. Antimicrob. Agents Chemother. 53(5):2205-2208.
28. Riedel CU, et al. 2007. Construction of p16Slux, a novel vector for improved bioluminescent labeling of Gram-negative bacteria. Appl. Environ. Microbiol. 73(21):7092-7095.
29. Tan Y, et al. 2007. Whole genome sequencing of a novel temperate bacteriophage of P. aeruginosa: evidence of tRNA gene mediating integration of the phage genome into the host bacterial chromosome. Cell. Microbiol. 9(2):479-491.
30. Van Regenmortel MHV, et al. 2000. Virus taxonomy: classification and nomenclature of viruses. Seventh report of the international committee on taxonomy of viruses. Academic Press, San Diego, CA.
31. Murphy FA, et al (ed.). 1995. Virus taxonomy: classification and nomenclature of viruses. Sixth Report of the International Committee on Taxonomy of Viruses, p. 51-63. Springer-Verlag, Vienna, Austria.
32. Ceyssens PJ, et al. 2009. Comparative analysis of the widespread and conserved PB1-like viruses infecting Pseudomonas aeruginosa. Environ. Microbiol. 11(11):2874-2883.
33. Ceyssens PJ, et al. 2008. The intron-containing genome of the lytic Pseudomonas phage LUZ24 resembles the temperate phage PaP3. Virology 377(2):233-238.
34. Ross P, Mayer R, Benziman M. 1991. Cellulose biosynthesis and function in bacteria. Microbiol. Rev. 55:35-58.
35. Zogaj X, Nimtz M, Rohde M, Bokranz W, Römling U. 2001. The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. Mol. Microbiol. 39(6):1452-1463.
36. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
37. O'May CY, Reid DW, Kirov SM. 2006. Anaerobic culture conditions favour biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. FEMS Immunol. Med. Microbiol. 48(3): 373-380.
38. Worlitzsch D, et al. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109(3):317-325.
39. Kirov SM, et al. 2007. Biofilm differentiation and dispersal in mucoid P. aeruginosa isolates from patients with cystic fibrosis. Microbiology 153: 3264-3274.
40. Shrout JD, et al. 2006. The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol. Microbiol. 62(5):1264-1277.
41. Purevdorj-Gage B, Costerton WJ, Stoodley P. 2005. Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms. Microbiology 151(5):1569-1576.
42. Webb JS, et al. 2003. Cell death in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 185:4585-4592.
43. Levin BR, Bull JJ. 2004. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2:166-173.
44. Hoffmann N, et al. 2005. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun. 73: 2504-2514.
45. Shen H, Han F, Yuzi Lin Y, Yu W. 2006. A high efficient electroporation of Pseudomonas sp. QDA pretreated with alginate lyase. Enzyme Microb. Technol. 39(4):677-682.
46. Alemayehu D, et al. 2009. Genome of a virulent bacteriophage Lb338-1 that lyses the probiotic Lactobacillus paracasei cheese strain. Gene 448(1): 29-39.
47. O'Sullivan D, et al. 2001. Naturally occurring lactococcal plasmid pAH90 links bacteriophage resistance and mobility functions to a food-grade selectable marker. Appl. Environ. Microbiol. 67:929-937.
48. Capra ML, et al. 2006. Characterization of a new virulent phage (MLC-A) of Lactobacillus paracasei. J. Dairy Sci. 89(7):2414-2423.
49. Moineau S, Pandian S, Klaenhammer TR. 1994. Evolution of a lytic bacteriophage via DNA acquisition from the Lactococcus lactis chromosome. Appl. Environ. Microbiol. 60:1832-1841.
50. Schatz MC, Phillippy AM, Shneiderman B, Salzberg SL. 2007. Hawkeye: an interactive visual analytics tool for genome assemblies. Genome Biol. 8(3):R34.
51. Gordon D. 2003. Viewing and editing assembled sequences using Consed. Curr. Protoc. Bioinformatics Chapter 11, Unit 11.2.
52. Ewing B, Green P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 8(3):186-194.
53. Delcher AL, Harmon D, Kasif S, White O, Salzberg SL. 1999. Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 27(23): 4636-4641.
54. Altermann E, Klaenhammer TR. 2003. GAMOLA: a new local solution for sequence annotation and analyzing draft and finished prokaryotic genomes. OMICS 7(2):161-169.
55. Aziz RK, et al. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75.
56. Carver T, et al. 2008. Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24(23): 2672-2676.
57. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
58. Tcherepanov V, Ehlers A, Upton C. 2006. Genome annotation transfer utility (GATU): rapid annotation of viral genomes using a closely related reference genome. BMC Genomics 7:150.
59. Darling AE, Treangen TJ, Messeguer X, Perna NT. 2007. Analyzing patterns of microbial evolution using the mauve genome alignment system. Methods Mol. Biol. 396:135-152.
60. Bruscia E, et al. 2002. Isolation of CF cell lines corrected at F508-CFTR locus by SFHR-mediated targeting. Gene Ther. 9(11):683-685.
61. Cozens AL, et al. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10(1):38-47.
62. Wirtanen G, Salo S, Helander IM, Mattila-Sandholm T. 2001. Microbiological methods for testing disinfectant efficiency on Pseudomonas biofilm. Colloids Surf. B Biointerfaces 20:37-50.